FDA Delays Leave Biotech Stocks in Limbo
Tuesday, March 25th, 2008A lack of resources leads the agency to push back drug approval deadlines, creating greater murkiness for an already tricky sector.
0 comments TheStreet.com | Stock Picks, Media, Uncategorized |